cdr

Hot Keywords
Drug Resistance Mechanisms Epigenetic Resistance in Cancer Therapy Biomarkers Pharmacogenetics of Cancer Liquid Biopsy Targeted Cancer Therapy Non-coding RNAs Kinase Inhibitors ABC Transporters

Top
The paper's citation list
No.The paper's citation list
1Current Technologies for RNA-Directed Liquid Diagnostics. 2021;13:5060 doi: 10.3390/cancers13205060
2MicroRNA-199b Deregulation Shows Oncogenic Properties and Promising Clinical Value as Circulating Marker in Locally Advanced Rectal Cancer Patients. 2022;23:2203 doi: 10.3390/ijms23042203
3Novel Biomarkers of microRNAs in Gastric Cancer: An Overview from Diagnosis to Treatment. 2022;11:12 doi: 10.2174/2211536611666220322160242
4 Noncoding RNAs in oral cancer . 2022; doi: 10.1002/wrna.1754
5Advantages and Challenges of Using ctDNA NGS to Assess the Presence of Minimal Residual Disease (MRD) in Solid Tumors. 2021;13:5698 doi: 10.3390/cancers13225698
6Identification of miR-20a-5p as Robust Normalizer for Urine microRNA Studies in Renal Cell Carcinoma and a Profile of Dysregulated microRNAs. 2021;22:7913 doi: 10.3390/ijms22157913
7MicroRNA-Mediated Metabolic Shaping of the Tumor Microenvironment. 2021;13:127 doi: 10.3390/cancers13010127
8Dietary stilbenes as modulators of specific miRNAs in prostate cancer. 2022;13: doi: 10.3389/fphar.2022.970280
9Potential utility of miRNAs for liquid biopsy in breast cancer. 2022;12: doi: 10.3389/fonc.2022.940314
© 2016-2023 OAE Publishing Inc., except certain content provided by third parties